Literature DB >> 3134293

A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes.

J F Brunet1, F Denizot, P Golstein.   

Abstract

One approach to the isolation of molecules involved in T cell-mediated cytolysis stems from the postulate of a possible correlation between molecular phenotype and molecular functional involvement. Accordingly, CTL-specific molecules have been looked for, using a strategy based on the differential screening of a subtracted cDNA library. This led to the isolation and characterization of the following structures, expressed mostly (but no exclusively) in CTLs and inducible upon lymphocyte activation: CTLA-1 and CTLA-3 (serine-proteases), CTLA-4 (a member of the Ig superfamily) and CTLA-2 alpha and beta (homologues to the proregion of cysteine-proteases). The theoretical and practical limitations and the prospects of this type of approach are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134293     DOI: 10.1111/j.1600-065x.1988.tb00747.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

Review 1.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

2.  Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA.

Authors:  Lingzhi Zhang; Hongruo Yun; Fiona Murray; Ruilin Lu; Lin Wang; Vivian Hook; Paul A Insel
Journal:  Cell Signal       Date:  2011-05-20       Impact factor: 4.315

3.  Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.

Authors:  H Reiser; G J Freeman; Z Razi-Wolf; C D Gimmi; B Benacerraf; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 4.  Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management.

Authors:  Paola Savoia; Chiara Astrua; Paolo Fava
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

Review 5.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 6.  Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?

Authors:  P S Linsley
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

7.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

Review 8.  CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations.

Authors:  Luis H Camacho
Journal:  Cancer Med       Date:  2015-01-25       Impact factor: 4.452

9.  Identification of CTLA2A, DEFB29, WFDC15B, SERPINA1F and MUP19 as Novel Tissue-Specific Secretory Factors in Mouse.

Authors:  Jibin Zhang; Jinsoo Ahn; Yeunsu Suh; Seongsoo Hwang; Michael E Davis; Kichoon Lee
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

10.  Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.

Authors:  Cinthia Silva-Vilches; Katrien Pletinckx; Miriam Lohnert; Vladimir Pavlovic; Diyaaeldin Ashour; Vini John; Emilia Vendelova; Susanne Kneitz; Jie Zhou; Rena Chen; Thomas Reinheckel; Thomas D Mueller; Jochen Bodem; Manfred B Lutz
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.